Publications
HIV and drugs: a common, common-sense agenda for 2016
2016 is set to be a historic year for people living with and affected by HIV and people who use drugs. The UN High-Level Meeting on AIDS offers an opportunity to fast-track the response to ending the AIDS epidemic, including progressive approaches to drugs policy.
2016 is set to be a historic year for people living with and affected by HIV and people who use drugs. The UN High-Level Meeting on AIDS offers an opportunity to fast-track the response to ending the AIDS epidemic, including progressive approaches to drugs policy.
Guidelines for the screening, care and treatment of persons with Chronic Hepatitis C Infection
Updated Version - April 2016 Guidelines
Updated Version - April 2016 Guidelines
Drug Use and Drug Policies in Sub-Saharan Africa
Important open access addition of International Journal of Drug Policy on Sub-Sahara Africa and how big a problem drug use and poor drug policies are, how these are affecting HIV epidemic in this area and some attempts at addressing this.
Important open access addition of International Journal of Drug Policy on Sub-Sahara Africa and how big a problem drug use and poor drug policies are, how these are affecting HIV epidemic in this area and some attempts at addressing this.
Through a Broken Glass, Darkly; Drug Policy and the War in Afghanistan
For more than fourteen years now, Washington has been pursuing a defined set of strategic objectives in Afghanistan. It has created and supported a client State on the standard model and imposed a specific and familiar economic regimen.
For more than fourteen years now, Washington has been pursuing a defined set of strategic objectives in Afghanistan. It has created and supported a client State on the standard model and imposed a specific and familiar economic regimen.
New treatments for hepatitis C virus (HCV): scope forpreventing liver disease and HCV transmission in England
New direct-acting antivirals have the potential to transform the hepatitis C (HCV) treatment landscape,with rates of sustained viral response in excess of 90%.
New direct-acting antivirals have the potential to transform the hepatitis C (HCV) treatment landscape,with rates of sustained viral response in excess of 90%.
Research Report: The New Zealand Drug Harm Index 2016
The New Zealand Drug Harm Index 2016 estimates the social cost of drug-related harms and intervention costs in 2014/15 as NZ$1.8 billion.
The New Zealand Drug Harm Index 2016 estimates the social cost of drug-related harms and intervention costs in 2014/15 as NZ$1.8 billion.
Trends in drug misuse deaths in England, 1999 to 2014
This report presents data on drug misuse deaths in England from 1999 to 2014. The Office for National Statistics reported a 17% increase in drug misuse deaths in England in 2014, following an increase of 21% in 2013.
This report presents data on drug misuse deaths in England from 1999 to 2014. The Office for National Statistics reported a 17% increase in drug misuse deaths in England in 2014, following an increase of 21% in 2013.
Hydromorphone vs. diacetylmorphine for long-term opioid addiction
In most analyses, injectable hydromorphone hydrochloride was not worse than diacetylmorphine hydrochloride to treat long-term severe opioid dependence and that could provide an alternative for patients where diacetylmorphine is unavailable due to political or regulatory reasons or for patients in whom it was unsuccessful, according to an article.
In most analyses, injectable hydromorphone hydrochloride was not worse than diacetylmorphine hydrochloride to treat long-term severe opioid dependence and that could provide an alternative for patients where diacetylmorphine is unavailable due to political or regulatory reasons or for patients in whom it was unsuccessful, according to an article.
